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ABSTRACT 
 
Gestational diabetes mellitus (GDM) is characterised by maternal hyper-
glyceamia first recognised during pregnancy. GDM produces chronic foetal 
hyperglyceamia and expressional changes in foetal endothelial cells (ECs).  
Epigenetic modulation of foetal endothelial genes by the intra-uterine envi-
ronment has been proposed. MicroRNAs (miRs) inhibit the expression of 
their mRNA targets and have been implicated in diabetes-induced endothe-
lial dysfunction. MiR-101 impairs EC in part via direct inhibition of the me-
thyltransferase Enhancer of Zester Homolog2 (EZH2) which catalysed the 
trimethylation on lysine 27 of histone H3 (H3K27m3). 
We aimed to characterize the molecular and functional impact of GDM on 
the foetal ECs derived from the umbilical cord vein (HUVECs).     
HUVECs prepared from GDM or healthy pregnancies, were assessed for 
apoptosis, migration, and angiogenic capacity. GDM-HUVECs showed de-
creased functional capacities, increased miR-101, reduced EZH2 and 
H3K27m3 expression. In GDM-HUVECs, miR-101 inhibition increased 
EZH2 expression, improved survival and endothelial functions. Moreover, 
cultured healthy-HUVECs were exposed to high (25mM, HG) or normal 
(5mM) D-glucose concentrations for 48 hours before being assessed for the 
aforementioned assay and for miR-101 and EZH2 expression. Similarly to 
GDM, in vitro HG impaired healthy-HUVEC function and elicited a concom-
itant increased in miR-101. 
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ABBREVIATIONS 
 
Gestational Diabetes Mellitus (GDM)  
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1. INTRODUCTION 
1.1  Gestational Diabetes Mellitus 
Gestational diabetes mellitus (GDM) is a syndrome characterised by glucose 
intolerance leading to maternal hyperglyceamia first recognized during 
pregnancy [1]. 
Approximately 7% of pregnancies are complicated by gestational diabetes 
mellitus (GDM) (ranging from 1 to 14%, depending on the population 
studied and the diagnostic tests employed) [2]. 
In GDM condition, the maternal hyperglyceamia leads to foetal 
hyperinsulinemia and may be responsible for adverse long-term maternal 
and foetus outcomes:  high risk for developing type 2 diabetes mellitus (DM) 
and cardiovascular diseases (CVD), atherosclerosis, increased perinatal 
morbidity (e.g. macrosomia, birth trauma, pre-eclampsia), and long-term 
consequences in offspring (e.g. childhood overweight, metabolic diseases 
that may increase risk of CVD and diabetes) [3]. 
The molecular mediators and signalling pathways from the mother to the 
developing foetus, involved in the program of the metabolic phenotype are 
not fully elucidated. There are evidences explaining that in diabetic 
condition, the high amount of maternal D-glucose can cross the placental 
barrier becoming available to the fetus, while maternal insulin does not 
cross the placenta, establishing chronic foetal hyperglyceamia. In fact, the 
developing foetal pancreas responds to an increased D-glucose load by 
increasing synthesis and release of insulin, which acts as a foetal growth 
hormone. This is the basic concept of the “Pedersen’s hyperglyceamia-
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hyperinsulinism hypothesis”, where fetal overgrowth due to 
hyperinsulinemia in response to increased transplacental D-glucose transfer 
is proposed, as recently reviewed [4] (Fig.1) explaining observations showing 
that offspring of diabetic mothers exhibit abnormal growth of the foetus 
(macrosomia) and high birth weight [5]. Moreover, the altered insulin 
signalling causes alterations in the physiology of the placenta, hormone-
induced dysfunction that could lead to the observed perinatal complications 
[6, 7, 8]. Further analysis expanded this theory, also other insulin 
secretagogues alterations, including free fatty acids, ketone bodies, and 
amino acids can contribute to the severity of the outcomes [9]. 
The clinical manifestations of GDM have been attributed mainly to the 
condition of hyperglycaemia, hyperinsulinemia, hyperlipidaemia, and foeto-
placental endothelial dysfunction [10, 11]. 
 
 
1.2  Endothelial Dysfunction in Gestational Diabetes Mellitus 
In GDM, various organs show structural and functional alterations, 
including endothelial dysfunction of the foeto-placental micro- and macro-
circulation [12, 13]. 
As early as in 1980 is known that maternal diabetes during pregnancy 
affects infant vasculature. Asmussen studied the umbilical vessels of infants 
born to women with type1 diabetes mellitus (T1DM) observing that the 
umbilical vessels showed pathological changes with early atherosclerosis, 
including focal intimal thickening and glycogen accumulations in the cells of 
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the intima and the media [14]. These altered metabolic phenotypes could 
partially be explained by the involvement of multiple mediators, a 
multifactorial contribution of nutrient- (e.g. D-glucose, fatty acids, 
aminoacids) and hormone- (e.g. insulin, leptin) triggered signals between 
the mother and the developing foetus. Also several inflammatory cytokines 
levels are elevated in diabetic and gestational diabetic mothers [15], and in 
obese pregnant women [16]. These changes in inflammatory cytokines are 
proposed as contributors and potential mediators of metabolic programming. 
Impairment of endothelial function often occurs prior to diagnosis of 
diabetes mellitus (DM) [17], and endothelial dysfunction is often present 
years before any signs of apparent microangiopathy [18]. Such findings have 
generated the hypothesis that, in diabetes, endothelial dysfunction may 
precede the development of chronic hyperglyceamia, encouraging the idea 
that the next generation of therapeutic agents should also focus on the 
mechanisms of endothelial dysfunction, and not only on glyceamic control 
[19]. 
A recent study has tested whether biomarkers of endothelial dysfunction 
may be altered in women with GDM and their foetuses. Has been 
demonstrated an increase in circulating adhesion molecules in patients with 
GDM. Moreover, GDM subjects had significantly decreased circulating 
Endothelial Progenitor Cell (EPC) counts in maternal blood, decreased 
Superoxide Dismutase (SOD) isoforms mRNA expression in both maternal 
and cord blood, and increased Endothelial NOS (eNOS) mRNA expression in 
both maternal and cord blood [20]. These findings are consistent with the 
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hypothesized mechanisms where hyperglycemia can lead to increased 
oxidative stress and endothelial dysfunction in diabetes. Importantly, these 
results suggest that alterations in endothelial function are present in both 
mothers and their fetuses in GDM pregnancies. Increased nitric oxide (NO) 
synthesis has also been reported in human placental veins and arteries [21] 
and in primary cultures of HUVEC isolated from pregnancies with GDM [22, 
23]. 
If these measures remain elevated, it is possible that these alterations can 
confer an increased risk for the development of CVD, atherosclerosis and 
type 2 DM.   
 
 
1.3  The ‘Glyceamic Memory ’ theory 
Clinical trials of diabetes patients (type 1 and 2) accent the importance of 
early and intensive treatment finalized to a good glyceamic control and 
bring attention to the prolonged damage of hyperglycemia on various organs. 
A good glyceamic control is recognised as an important component in the 
clinical treatment of diabetes. The strategies based on intensive blood-
glucose-lowering have confirmed the clinical relevance of strict metabolic 
regulation to attenuate diabetic vascular complications [24, 25, 26]. 
The concept of ‘metabolic or glycemic memory’ started more than 20 years 
ago, where epidemiological studies demonstrated that, despite stringent 
long-term glycemic control, the previous hyperglyceamia affects the 
vasculature leading persistent alterations [24, 25, 26]. Even experimental 
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studies on animal models had suggested that prior hyperglycemia induces 
memories affecting endothelial cells with persistent effects, which may be 
responsible for the development of chronic vascular complications associated 
with diabetes [27, 28]. 
Recently, strong experimental evidences support the role of gene-regulating 
events conferred by hyperglyceamia on the development and persistence of 
vascular complications due to diabetes. These heritable gene-alterations 
have been associated with deregulation at level of epigenome (chromatin 
histone modifications, DNA methylation). In fact, glucose-mediated 
chromatin and transcriptional changes has been found in vascular cells 
cultured in high glucose, in association with persistent inflammation [29, 30, 
31]. These in vitro studies have opened the possibility that similar 
mechanisms may operates also in the microvasculature. 
A better understanding of the molecular events and transcriptional gene-
regulation mediated by chromatin modification will help to identify novel 
approaches to inhibit, attenuate, or reverse the persistent deleterious 
consequences of diabetes. 
 
 
1.4  The role of microRNAs in endothelial dysfunction 
MicroRNAs (miRNAs) are small non coding RNA molecules (~22 nucleotide) 
able to modulate many molecular pathways involved in both physiological 
and pathological process acting on target gene: inhibiting the mRNA 
translation and/or causing its degradation [32]. 
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The first study describing miRNAs involvement in endothelial cells exposed 
to high glucose is Wang et al [33]. They found elevated miR-320 levels in 
ECs derived from diabetic rats, accompanied by decreased proliferation and 
migration. After, many other authors have increased the number of miRNAs 
involved in hyperglyceamia, diabetes, angiogenesis and endothelial 
dysfunction. MiRNAs can have a protective and pro-angiogenic effect or 
exert a deregulation/inhibition of angiogenesis, contributing to the 
development of vascular complication (Table I).  
 
 
1.5  The epigenetic regulator Enhancer of Zester Homolog2 (EZH2) and its 
role in endothelial dysfunction 
The protein Enhancer of Zester Homolog2 (EZH2) is a well-characterized 
regulator of the epigenome, it functions as a histone methyltransferase in 
the Policomb Repressor Complex2 (PRC2), which contains EED, SUZ12, and 
other proteins [34]. PRC2 initiates and maintains the methylation of histone 
H3 on Lysine 27 (H3K27). The epigenetic mark H3K27m3 mediates the long 
term epigenetic gene silencing [34]. In fact, according to the ‘histone code’ 
hypothesis, histone marks are deposited by ‘writer’ proteins as EZH2 and 
recognized by ‘reader’ proteins, that together with chromatin regulators 
trigger the transition between open (permissive) or close (non-permissive) 
chromatin, regulating gene transcription (Fig.2). PRC2, like other 
epigenome regulators, works in complex. It’s physically and functionally 
linked with histone deacetylases (HDACs), with histone methyltransferase 
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(HMTs) [35], and other proteins. In particular, one of them is the Jumonji 
domain family histone H3K36me2 and H3K4me3 demethylase KDM2B (or 
NDY/FBXL10/JHDM1B) [36], which play a central role in the ‘repressive 
histone code’ by removal of the active marks H3K36m2 and H3K4m3. The 
functional interaction between EZH2 and KDM2B is not completely 
elucidated, even though has been showed that they are coordinately down-
regulated in a series of primary cells undergoing senescence [37]. 
Again, it has been shown that EZH2 is involved in the maintenance of 
pluripotency in human stem cells [38, 39], but little is known about its 
function in differentiated cells. 
However, recent studies have suggested a physiological role for EZH2 in 
endothelial function, mediated by miR-101. The authors identified a pro-
angiogenic VEGF/miR-101/EZH2 axis, providing evidence for a functional 
link between: growth factor-mediated signaling, post-transcriptional 
silencing through miR-101 on its target gene EZH2, epigenetic modifications 
through histone-methylation, and the angiogenic process [40, 41]. 
Currently, has been identified the role of EZH2 in endothelial cells using 
knockdown (KD) strategy. The authors have reported 946 Ezh2 target genes 
regulated by more than 2-fold change; almost two thirds of the genes were 
up-regulated after EZH2 KD, which is in accordance with its repressive 
function. Having identified genes that contain the histone modification 
H3K27m3 and genes regulated on the mRNA level by EZH2 silencing, in 
endothelial cells, they could identify direct EZH2 target genes. Basically, 
they combined the results of the ChIP-on-chip with the EZH2 knockdown 
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expression arrays. Some of the putative target genes identified are known to 
play a role in the regulation of vascular cell proliferation, spreading, and 
angiogenesis, such as fibroblast growth factor 1 (FGF-1), cadherin-13, 
disintegrin and metalloproteinase domain 12, frizzled homolog 7, 
transforming growth factor-α (TGF-α), hairy/enhancer of-split related with 
YRPW motif 2, and versican. In addition, other EZH2 target genes were 
already implicated in endothelial dysfunction and cardiovascular disease 
such as interleukin-1β (IL-1β), insulin-like growth factor-2 (IGF-2), bone 
morphogenetic protein receptor-1A (BMPR-1A), spondin-1 (SPON-1), 
interleukin-11 (IL-11), inducible nitric oxide synthase (iNOS), transforming 




1.6  FGF2 or VEGF/KDM2B/EZH2/miR-101/EZH2 axis 
The FGF-2-KDM2B/EZH2-miR-101-EZH2 axis, firstly studied in tumor cells, 
and documented also in primary fibroblasts in culture [36], has been 
recently analysed in endothelial cells as one of the pathways activated in 
response to VEGF [40, 41], as mentioned before. 
Pathologically, what it’s known is that EZH2 overexpression, common in 
both hematopoietic malignancies and solid tumors, promotes cell 
proliferation, migration and invasiveness. Moreover, the overexpression of 
EZH2 in the tumor stroma stimulates angiogenesis [38, 41, 43], while the 
pharmacologic disruption of the EZH2-containing PRC2 complex induces 
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apoptosis in cancer cells and increase the sensibility to the radiation [44]. 
The high EZH2 levels in tumor cells are associated with the down-
regulation of miR-101, which targets EZH2 [40, 41, 45, 46]. The repression 
of miR-101 is the result of chromatin modifications induced by histone 
demethylase KDM2B (or NDY1) on specific regulatory region of miR-101 
locus [45]. The upregulation of KDM2B in these tumors is cell autonomous; 
it’s driven by growth factor signals, like fibroblast growth factor-2 (FGF-2) 
and (VEGF) via CREB phosphorylation and activation, downstream of the 
DYRK1A kinase. The upregulation of KDM2B triggers the recruitment of 
basally expressed EZH2, which binds and represses the miR-101 locus in 
concert with NDY1. The repression of miR-101 leads to the upregulation of 
EZH2, which in addition to its direct effects on gene expression, stabilizes 
the NDY1-initiated repression of miR-101, and regulates miR-101 target 
genes. (Fig. 3) [45]. 
 
Cancer is another pathology directly dependent on angiogenesis and it is not 
surprising that diabetes is positively correlates with hepatic, pancreatic, 
colon, endometrial, breast, and bladder cancer incidence and prognosis [47, 
48], but negatively with prostate cancer [49, 50]. Thus, both angiogenesis in 
organs and tumour growth are regulated in a tissue-specific manner in 
patients with diabetes. Similar to the mechanisms of diabetic tissue-specific 
aberrant angiogenesis, the molecular mechanisms of positive or negative 
tissue-specific associations of tumour growth and diabetes are unknown. 
 
14 
Ilaria Floris, “Characterisation of molecular and phenotypic effects induced by Gestational Diabetes 
Mellitus (GDM) on endothelial cells and placenta tissue”, PhD thesis in Biochemistry, Physiology and 
Molecular Biology of PhD School in Biomolecular and Biotechnological Sciences, University of Sassari 
1.7  Placenta 
The human placenta is the highly specialised organ supporting the normal 
growth and the development of the foetus. The placenta provides oxygen 
and nutrients to the foetus, while eliminate carbon dioxide and other waste 
products. The placenta can help to protect the foetus against certain 
xenobiotic molecules, infections and maternal diseases, furthermore, can 
release hormones into both the maternal-foetal circulation to affect 
pregnancy, metabolism, foetal growth, parturition and other functions.  
The main functional units of the placenta are the chorionic villi, which 
gradually branched into smaller intermediate and terminal villi. The villi 
are surrounded mainly by a syncytiotrophoblast layer in which the nuclei 
are often grouped together to form syncytial knots. The maternal blood 
circulate in the intervillous space, while the foetal blood is separated from 
maternal blood by only three or four cell layers (placental membrane) in the 
surrounding intervillous space. The centre of the villi contained loose 
mesenchymal tissue with fibroblasts, macrophages and blood vessels. (Fig.4) 
 
 
1.8  Placental dysfunction in Gestational Diabetes Mellitus 
In GDM mothers, the increases in circulating glucose concentration may 
affect the placental angiogenesis.  
During the entire gestation, maternal and foetal tissues interact to establish 
an appropriate vascularization in the placental decidua and chorion. 
Decidual angiogenesis involves proliferation, migration and maturation of 
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maternal and foetal endothelial cells. An increase in glucose can affect the 
endothelial physiology, compromising the placental angiogenesis, function 
and the foetal development [51, 52].  
The chronic maternal and foetal hyperglyceamia can promote 
atherosclerosis and consequent hypoxia/ischemia with problem in blood flow, 
increases in syncytial knots and in fibrin deposition. Hyperglyceamia has 
been also associated with higher deposition of the extracellular vascular 
amyloid, which consists on a heterogeneous mix of fibrillar proteins [53, 54]. 
The production of these proteins may explain the appearance of more 
condensed mesenchyme around blood vessels.  
In addition to amyloid deposition, hyperglyceamia also causes exacerbated 
collagen production by the vascular endothelium. A study indicate that the 
accumulation of collagen in the tunica media of vessels in intermediate villi 
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2. MATERIALS AND METHODS  
Human umbilical cords and study groups 
Umbilical cords were collected after delivery from 24 full-term normal or 22 
full-term gestational diabetic pregnancies (Table I). The investigation 
conforms to the principles outlined in the Declaration of Helsinki. Ethics 
Committee approval from the Faculty of Medicine of the University of 
Sassari and patient informed consent were obtained. Patients with basal 
glycaemia 90 mg/dL (i.e. overnight starvation) and 140 mg/dL at 2 h after an 
oral glucose load (75 g) were diagnosed as gestational diabetes (Table II). 
 
Human endothelial cells extraction 
Primary endothelial cells (HUVECs) obtained from healthy and gestational 
diabetic mothers were extracted from umbilical cord vein. Umbilical cord vein 
were washed in PBS and gently massed to push the blood out. The ECs were 
detached from the lumen of the vein by treatment with collagenase. The 
incubation were performed for 10 min at 37°C with 0.05% (w/v) collagenase 
type II from Clostridium hystolyticum (Sigma) in medium M199 (Invitrogen) 
containing 100 U/ml of penicillin G sodium salt and 100μg/ml streptomycin 
sulfate (Sigma). Then, the cellular suspension has been collected and 
centrifuged at 1000×g for 10 min. The ECs were resuspended in 5 ml of 
medium M199 supplemented with 10% (v/v) foetal calf serum (FCS), 10% 
(v/v) newborn-calf serum (Invitrogen, Carlsbad, CA), 2mM glutamine and 
antibiotics, then plated in 25 cm2 tissue culture flasks (Falcon, Oxnard, CA) 
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pre-treated with 0.1 % gelatin and cultured in an atmosphere of 5% CO2/95% 
air. 
The human cells were extracted in the University of Sassari, kept in culture 
until passage two, then stored and imported for research at the University 
of Bristol following ethical approval (NRES/REC reference: 12/WM/0366 for 
the IRAS protocol 113869). 
 
Cell culture 
Primary endothelial cells (HUVECs) obtained from healthy and gestational 
diabetic mothers, were cultured in EGM2 medium (Lonza) with 10% FBS 
(foetal bovine serum). The cellular purity was tested by FACS using CD31 
(1:100) as endothelial marker (Fig. 5). 
 
High Glucose experiments 
The HUVECs obtained from healthy donors were cultured in high D-glucose 
(SIGMA) to mimic the hyperglycaemic conditions choosing two different 
final concentrations: 12.5mM and 25mM. L-glucose (SIGMA) has been used 
to make the osmotic control for each condition, adding L-glucose to the 
EGM2 up to raise the same final concentration of D-glucose. The time-points 
of treatment are: 12 – 24 - 48 hours. For each time-point the cells has been 
analysed in their phenotypic properties with functional assays in association 
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HUVECs functional assay 
The HUVECs has been analysed for their endothelial phenotypic properties 
with functional assays to characterise: 
- the effects of high glucose in vitro; 
- the phenotype of the HUVECs extracted from gestational diabetic 
mothers compared to the lineages extracted from ‘healthy’ mothers donor. 
 
1. BrdU incorporation assay was used to test the proliferative capacity of 
the HUVECs. The assay was performed in a 96-well format using a 
commercially available colorimetric enzyme-linked immunosorbent assay kit 
(ROCHE). To test the effects of the high D-glucose, 150.000 cells/well has 
been placed in a 6-well plate then, after 12 – 24 – 48 hours and 6 days of 
treatment, trypsinized and plated in the 96-well for the assay (2000 
cells/well); after 24 hours of BrdU incorporation the cells were fixed and 
analysed. The index of proliferative capacity in response to FBS, has been 
calculated firstly maintaining the HUVECs for 1 hour without FBS then, 
culturing each lineage with 0.5% FBS and with 10% FBS for 24 hours, in 
presence of BrdU. Then, fixed the cells and performed the BrdU assay. The 
ratio between the average of proliferative capacity of cells cultured with 0.5% 
FBS and the average of proliferation occurred with 10% FBS, could gave us 
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2. Scratch assay was assessed to test the effect of high glucose on the 
migration capacity. The cells were cultured in a 12-well plate (30.000 – 
50.000 cells/well) and treated with D-glucose (and L-glucose) for 12 – 24 – 48 
hours and 6 days. Then, in the monolayer has been made manually the 
scratch with pipette tip, changed the medium with fresh EGM2 (10% FBS) 
adding 2mM hydroxyurea (SIGMA) to induce growth arrest. Images were 
taken at 0, 6 and 10 hours at 5X using a Brightfield inverted microscope. 
The wound area was measured using ImageJ software (NIH) and 
normalized to time 0 wounds to calculate the velocity of closing scratch in 
the first 6 and 10 hours; the final value has been obtained as the average 
between the velocity of closing scratch at 6th and 10th hour. 
 
3. The angiogenic capacity has been tested with the matrigel assay, using 
the Matrigel matrix (BD Matrigel basement membrane complex) as 
substrate for the successful endothelial cell tube formation and allows the 
study of angiogenesis in vitro. The cells, followed the high glucose treatment, 
or transfection, has been placed on matrigel (15.000 cells/well on 40 µl of 
already solidified matrigel, in triplicate, using 96-well format). The images 
were taken after 6 and 24 hours at 5X using a Brightfield inverted 
microscope. The total length of tubes (mm) has been calculated as 
parameter of angiogenic capacity in vitro. 
 
4.  The apoptosis has been studied by the kit Cell Death Detection ELISA 
(ROCHE). 
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D-glucose treated cells, after 24 – 48 hours and 6 days were used for the 
ELISA (100.000 cells/per condition). The ELISA is specific to detect the 
mono- and oligo- nucleosome in the cytoplasmic fraction of the cells lysate. 
In fact, apoptosis is accompanied by membrane blebbing, condensation of 
cytoplasm and activation of endogenous endonuclease. The enrichment of 
mono- and oligo- nucleosomes in the cytoplasm of the apoptotic cells is due 
to the DNA degradation and occurs several hours before the plasma 
membrane breakdown. For the ELISA assay, the cellular pellet has been 
incubated with the Incubation Buffer furnished by the kit for 30 minutes; 
then centrifuged at 20.000 g for 10 minute to obtain the cytosolic fraction in 
the supernatant. It has been collected and used for the photometric enzyme 
immunoassay. The values of absorbance have been reported in fold change. 
 
Conditioned Medium preparation 
HUVECs from ‘healthy’ and GDM mothers (N=4) were cultured in 6well-
plate (150.000 cells/well), then starved strongly for 1 hour in EGM-2 without 
FBS. Thereafter, media was replaced with 0.5%FBS and cells were 
incubated for another 24 hours. Subsequently, conditioned media was 
collected, centrifuged and stored at −80°C until further analysis. 
 
ELISA 
We measured secreted FGF2 (or basic FGF) and VEGF (VEGF165, VEGF121, 
VEGF165b) in the conditioned medium samples using the Duo Set ELISA 
Development kit (human VEGF Duo Set, R&D Systems; Minneapolis, MA, 
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USA). ODs were measured at 450–570 nm and FGF2 or VEGF was 
calculated as cell number adjusted amount (ng/ml) according to the 
standards used. The EGM-2 media with 0.5% serum served has been used 
as negative control. 
 
Transfection 
12.5nM of scramble control (Ambion), pre-miR-101 (Ambion), anti-miR-101 
(Ambion), EZH2 siRNA (Qiagen) or siRNA-AF (Qiagen) oligonucleotides 
were transfected into HUVECs using Lipofectamin2000 (Invitrogen), 
according the manufacturer’s protocol. After 5 hours, the transfection 
medium was replaced by EGM2 (10% FBS) until further analysis. 
 
mRNA and miRNAs RT-PCR analysis 
Total RNAs were isolated by TRizol method, and reverse transcription was 
performed using the QIAGEN QuantiTect Reverse Transcription kit, 
according to the manufacturer’s protocol. 
MRNA levels of EZH2, KDM2B, VEGF-A have been analysed. Their levels 
normalized to beta actin, chosen as housekeeping gene. 
For miRNAs analysis, reverse transcription was performed using the 
TaqMan MicroRNA Reverse Transcription kit (Ambion), Real-time PCR was 
performed using the TaqMan universal master mix in the Light- Cycler480 
qPCR detection system (Roche). Primers for RT and qPCR were included in 
TaqMan MicroRNA assays from Ambion (see online supplement). RNU6B 
was used as a reference for normalization. 
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Relative levels of mRNA and miRNAs were defined from threshold cycle (Ct) 
values calculated by the 2 –ΔΔCt method. 
 
Western Blot assay 
Total protein or nuclear protein fraction extracted from HUVECs were 
loaded, subjected to SDS–PAGE and blotted on PVDF membranes.  
For the total lysate, cells were washed in cold PBS and lysate with RIPA 
buffer (150mM sodium chloride, 1.0% Triton X-100, 0.5% sodium 
deoxycholate, 0.1% SDS-sodium dodecyl sulphate, 50mM Tris, pH 8.0) 
supplemented with protease inhibitors (1mM DTT, 0.5mM PMSF, 2 ul/ml 
Protease Inhibitors Cocktails, Sigma).  
For the nuclear/cytoplasmic protein separation, has been followed the 
protocol: briefly, cells were washed twice with cold PBS then resuspended in 
buffer A (10mM Hepes pH 7.5, 10mM KCl, 1.5mM MgCl2, 0.34M Sucrose, 10% 
Glicerolo, 0.1% TritonX-100) supplemented with protease inhibitors (1mM 
DTT, 0.5mM PMSF, 2 ul/ml Protease Inhibitors Cocktails, Sigma) and 
incubated at 4ºC on a rotator for 30 minutes to help the lysis. By 
centrifuging at 6500×g for 5 minutes at 4 °C nuclei were isolated, washed 
once with buffer A (depleted of Triton X-100) and subsequently resuspended 
in buffer B (3mM EDTA, 0.2mM EGTA, plus protease inhibitors, as buffer A). 
Blots were incubated over night at 4°C with primary antibodies against 
EZH2 (Active Motif, 1:2000); anti-trimethyl-Histone H3 (Lys27) (UPSTATE 
Cell Signaling, 1:2000); alpha/beta tubulin (Cell Signaling, 1:2000), actin 
(Santa Cruz, 1:1000); anti-Histone H3 (Active Motif, 1:2000); anti-LaminA/C 
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(Active Motif, 1:1000) and an HRP-conjugated secondary antibody, followed 
by chemiluminescence detection. Levels were visualized on X-ray film (GE 
healthcare) and quantified using ImageJ software (NIH Image). 
 
ChIP 
Chromatin immunoprecipitation (ChIP) assays were performed using 
gestational diabetic and ‘healthy’ HUVECs or ‘healthy’ HUVECs exposed to 
normal and high D-Glucose concentration (respectively 5mM and 25mM).  
Cells were fixed in 1% formaldehyde/PBS; after 10 minute of incubation at 
RT, the cross-linking has been stopped by adding glycine to a final 
concentration of 0.125M. The cells were washed in PBS and harvested in 
SDS buffer (100mM NaCl, 50mM Tris-HCl (pH 8), 5mM EDTA (pH 8), 0.2% 
NaN3, SDS 0.5%).  The chromatin pellet has been obtained by centrifuging 
6 min at 1200 rpm at 4°C. The only surnatant kept and resuspended to the 
final volume of 300 µl with ice-cold IP Buffer (= 1 vol of SDS Buffer : 0.5 vol 
Triton Diluition Buffer). Triton Diluition Buffer made with 100mM Tris-HCl 
(pH 8.6), 100mM NaCl, 5mM EDTA (pH 8), 0.2% NaN3, 5% Triton-X100. 
The chromatin were sonicated and then incubated with magnetic beads and 
specific antibodies against EZH2 (mouse monoclonal, Active motif, Lot 
2023363) and control IgGs. Aliquots of immunoprecipitated DNAs were 
analyzed in triplicate by real-time quantitative PCR with the primers 
specific for the promoter region of miR-101 gene. Enrichment (n-fold) of 
target genomic regions immunoprecipitated by each specific antibody was 
normalized to the levels obtained with species-matched control IgGs and 
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After fixation, the human placental samples from ‘healthy’ and GDM 
mothers (N=2), were washed in PBS and processed for embedding in 
paraffin. Deparaffinized sections 5 mm thick were stained with 
hematoxylin-eosin to identify the villous and the decidual placental regions. 
Samples from two different paraffin blocks of each placenta were analyzed. 
 
Picrosirius Red staining 
Hyperglycemia can lead to the exacerbated production of collagen by the 
vascular endothelium. To assess collagen production by placental tissue, 5 
mm-thick sections were stained with Picrosirius Red, which allows the 
visualization of collagen fibers by light microscopy (red staining) or 
polarized light microscopy [54]. After deparaffinization, the sections were 




Data are expressed as means ± SEM from at least three independent 
experiments. Differences between D-glucose treated HUVECs compared to 
normal glucose-controls or between gestational diabetic compared to 
‘healthy’ HUVECs were tested using unpaired Student’s t test, just if the 
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Normality test has been passed, otherwise using the Mann-Whitney Rank 
Sum Test. Statistical analyses were performed using GraphPad Prism 
version 5.0 and SigmaStat 3.1; P values < 0.05 were considered statistically 
significant. Pearson’s correlation and respective p value has been calculated 
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3. RESULTS   
  
3.1 Gestational diabetes induces long term phenotypic alterations on 
HUVECs  
The characteristic of the donor mothers is presented in Table II. The 
HUVECs has been extracted from ‘healthy’ (Ctr-HUVECs) and gestational 
diabetic mothers (GDM-HUVECs), as described in the protocol. The purity 
of the cells has been investigated by FACS using the endothelial marker 
CD-31. As the figure Fig. 5 shows, both GDM-HUVECs and Ctr-HUVECs 
are CD-31 positive (>95%). 
It was already shown that endothelial cells isolated form diabetic donors 
conserve a ‘glyceamic memory’ in culture [55] suggesting that long-term 
chronic hyperglyceamia induce persistent outcomes. In fact, in comparison 
with ‘healthy’ controls, GDM-HUVECs showed reduced capacity to form 
cellular network on Matrigel (Fig. 6); a lower proliferative index after 
stimulation with foetal bovine serum (FBS) (Fig. 7); impaired migration 
capacity (measured in ‘scratch assays’) (Fig. 8);  and increased apoptosis 
(Fig. 9). In our study the findings are consistent with the hypothesized 
mechanisms where hyperglyceamia leads to endothelial dysfunction due to 
diabetes. Moreover, the observed endothelial cell phenotype were present 
after five-six passages in culture in normal D-Glucose condition and 
represents long-term effect of maternal GDM environment in utero. Our 
study is in line with the ‘glyceamic memory’ theory, where previous 
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hyperglycaemia confers persistent effects on vasculature, even if returned to 
normal glucose levels. 
 
3.2 MicroRNA expressional analysis in GDM-HUVECs and Control-
HUVECs 
In association with the phenotypic characterisation, the HUVECs from 
‘healthy’ and from GDM mothers has been screened for the microRNAs 
belonging to the extended miR-16 family (miR-15a, miR-15b, miR-16, miR-
103, miR-107, miR-195, miR-424 and miR-497, miR-503), already involved 
in diabetes and its vascular complications [56, 57, 58], and for microRNA-
101, which was previously shown to inhibit angiogenesis by targeting the 
epigenetic enzymes EZH2 [40, 45, 46]. As shown in Fig. 10, a pilot 
expressional screening using n=8 samples per group showed no statistical 
significant differences in the miRs levels, but a trend toward increased 
levels in the GDM-HUVECs compared to the ‘healthy’ HUVECs. The miR-
101 data was assessed with a larger number of samples (n=18), and we 
found higher levels in the GDM-HUVECs compared with the controls 
(P<0.05) (Fig.11a, b). Moreover, we found very high positive Pearson’s 
correlation between miR-101 levels and the apoptosis measured in ‘healthy’ 
and GDM-HUVECs (Pearson r = 0.9, P<0.001) (Fig.12). 
 
3.3 Gestational diabetes induces changes in the components of the FGF2-
VEGF/KDM2B/EZH2-miR-101-EZH2 axis  
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GDM reportedly can induce epigenetic changes at the level of DNA 
methylation in various foetal organs [59], including the placenta [60]. In our 
study, in association with the higher miR-101 levels (Fig. 11a, b), the 
epigenetic histone methyltransferase EZH2 were found lower in GDM-
HUVECs compare with the ‘healthy’ HUVECs lineages (P<0.05), both in 
mRNA (Fig.11 c, d) and in protein levels (Fig.11f). Moreover, Fig.11e shows 
the negative Pearson’s correlation found between miR-101 levels and EZH2 
mRNA levels, confirming previous reports which have validated EZH2 as a 
target-gene of miR-101 in HUVECs [40, 45, 46]. We measured by Western 
Blot also the levels of H3K27m3, normalising to the levels of histone H3, 
and we found that even the epigenetic mark were lower in the GDM-
HUVECs compared to the controls (P<0.05) according to the EZH2 levels 
(Fig. 11f). 
We have examined changes of the other axis components. To investigate the 
autocrine signalling, specifically of the two growth factors responsible for 
axis activation, we cultured both groups of cells in serum starved condition 
for 24 hours (as specified in the methods), then we collected the conditioned 
medium (CM) and we analysed by ELISA the levels of FGF2 and VEGF. As 
shown in the figure Fig. 13a, b, we found lower FGF2 concentration in CM-
GDM HUVECs compare with the CM from controls (P<0.05), while just a 
tendency toward lower VEGF concentration in CM from GDM HUVECs. 
The graphs in the figure (Fig. 14a, b) represent the VEGF and KDM2B 
mRNA levels, measured in the HUVECs extracted from healthy and 
gestational diabetic mothers. Their levels tend towards a decreased in the 
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GDM lineages compare to the control, but without statistical difference. 
Coherently with the axis, and with other studies in which is shown the 
EZH2 transcriptional activation directly mediated by VEGF in endothelial 
cells, through the transcription factor E2F [61], we have found a positive 
Pearson’s correlation between VEGF and EZH2 mRNA levels (Pearson r = 
0.7 ; P<0.0005) (Fig. 14c). 
Again, in accordance with the axis, we found positive correlation between 
EZH2 and KDM2B (Pearson r = 0.71; P<0.0005) and negative Pearson’s 
correlation between miR-101 levels and KDM2B (Pearson r = - 0.63 ; 
P<0.005) (Fig. 14d, e). 
 
3.4 Functional role of miR-101 in GDM HUVECs 
To study the impact of miR-101 in GDM-HUVECs, cells were transfected 
with pre-miR-101, anti-miR-101, scramble control or non-transfected. Fig. 
15a shows miR-101 changes in response to successful transfection. 
Moreover, EZH2 mRNA (Fig. 15b) and protein (Fig. 16) levels changed 
accordingly. The epigenetic mark H3K27me3 catalysed by EZH2 was 
decreased in GDM-HUVECs after pre-miR-101 transfection, in line with the 
EZH2 expressional changes (Fig.16); on the other side we found just a trend 
toward an increased H3K27m3 levels after anti-miR-101 transfection 
compared to the scramble control.    
Next, we assessed the functional role of miR-101 in GDM-HUVECs (using 
healthy HUVECs for reference). Pre-miR-101 transfection reduced cell 
vitality (Trypan blue exclusion assay – Fig. 17a), while anti-miR-101 
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reduced apoptosis (Fig. 17b) of GDM-HUVECs. Importantly, the GDM-
HUVEC capillary-like tube formation capacity on Matrigel was improved to 
the level of healthy HUVECs by anti-miR-101 (Fig. 17c). By contrast, 
changes in miR-101 expression did not influences the capacity of GDM-
HUVEC to proliferate (BrdU incorporation data not shown) and only pre-
miR-101 induced altered migratory capacity in GDM-HUVECs, while anti-
miR-101 elicited not effect (Fig. 18). 
In the light of the results we may conclude that the higher miR-101 levels 
and the decreased EZH2 levels found in GDM-HUVECs, can partially 
explain their impaired in vitro phenotypic properties compare with the 
controls. In fact, anti-miR-101 GDM-transfected cells, accompanied by 
restored EZH2 levels, have improved the capillary-like tube formation 
capacity on Matrigel and reduced apoptosis, similarly to the HUVECs 
derived from ‘healthy’ mothers. 
 
3.5 EZH2 knock down induces apoptosis in vitro in GDM-HUVECs  
To understand the role of EZH2 knock down in GDM HUVECs, firstly we 
examined the EZH2 inhibition testing the siRNA-mediated knock down of 
EZH2 (EZH2-siRNA) compare with the siRNA-control (siRNA-Ctr). As 
shown in Fig. 19, 12.5nM of siRNA-EZH2 were able to inhibit EZH2 protein 
levels by about 90% compared to the siRNA-Ctr (P<0.05) and to reduce 
H3K27m3 by about 20% (P<0.05) in both GDM-HUVECs and control-
HUVECs. Sure about the siRNA specificity, we analysed the effect of EZH2 
knock down (EZH2 KD) compared to the siRNA-Ctr, on miR-101 expression 
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levels (Fig. 20), on apoptosis (Fig. 21a) and on angiogenic capacity in vitro 
(Fig. 21b). In the figure Fig. 20, it’s shown that miR-101 increased in GDM-
HUVECs due to EZH2 KD (P<0.05 vs siRNA-Ctr), in accordance with 
published study [45] and tends toward an increased in Ctr-HUVECs (P=0.1 
vs siRNA-Ctr). Moreover, the miR-101 increased is accompanied by 
augmented apoptosis in EZH2-siRNA transfected GDM-HUVECs (P<0.05 vs 
siRNA-Ctr) as expected (Fig. 21a). 
Surprisingly, the GDM-HUVECs in vitro angiogenic capacity, already 
impaired by the previous hyperglycaemic environment, seems not be 
influenced by the EZH2 KD (Fig. 21b) differently from what we observed in 
the pre-miR-101 transfected cells (Fig. 17c). One possible explanation could 
be that, miR-101 levels reached with pre-miR-101 are much higher than the 
levels produced in EZH2 KD transfected cells, as shown the figure Fig. 22. 
 
3.6 EZH2 knock down induces apoptosis in anti-miR-101 transfected GDM-
HUVECs  
We wanted evaluate also if the rescue observed with the anti-miR-101 can 
be annulled by the simultaneous down-regulation of EZH2. To answer that 
question, we performed the co-transfection with EZH2-siRNA/anti-miR-101, 
siRNA-Ctr/anti-miR-101, or siRNA-Ctr/scramble in GDM-HUVECs. 
In response to the transfection, EZH2 mRNA levels increased with siRNA-
Ctr/anti-miR-101 and decreased with siRNA-EZH2/anti-miR-101 compared 
to the control (Fig. 23a). Again, as expected miR-101 decreased in siRNA-
Ctr/anti-miR-101 transfected cells compared to the control (Fig. 23b) and 
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that is accompanied by decreased apoptosis (P<0.05 vs siRNA-Ctr/scramble) 
and improved capillary network on Matrigel (P<0.05 vs siRNA-
Ctr/scramble) (Fig. 24a&b). As previously mentioned, because EZH2 KD 
leads to increased miR-101 levels, we found no change in miR-101 levels 
between siRNA-Ctr/scramble and EZH2-siRNA/anti-miR-101 transfected 
cells. Moreover, the functional assays showed increased apoptosis in EZH2-
siRNA/antimiR-101 transfected cells compared to siRNA-Ctr/anti-miR-101 
and to siRNA-Ctr/scramble (Fig. 24a) and no changed in the capillary-like 
tube formation on Matrigel (Fig. 24b). In conclusion, EZH2 KD in anti-miR-
101 transfected GDM-HUVECs increased apoptosis, while has no effect on 
angiogenic capacity in vitro compare with the only anti-miR-101 transfected 
cells, probably due to the contribute of other miR-101 targets involved in 
pathways controlling angiogenesis. 
 
3.7 Analysis of EZH2 occupancy at miR-101 locus by chromatin 
immunoprecipitation (ChIP)  
We hypothesized that EZH2 is required for the repression of miR-101 and 
that the lower EZH2 levels found in GDM-HUVECs may be responsible of 
the higher miR-101 levels. In fact other study demonstrated that the 
complex KDM2B/EZH2 binds miR-101 locus causing its repression on the 
transcriptional levels [45]. We demonstrated that EZH2 KD caused miR-101 
increase in GDM-HUVECs (Fig. 20), and a tendency toward higher miR-101 
levels in EZH2-siRNA GDM-HUVECs than the EZH2 KD Ctr-HUVECs 
(P<0.1). We aimed demonstrate that EZH2 occupancy at the promoter 
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region of miR-101 locus is poorer in the GDM lineages compare with the 
controls, leading higher accessibility to transcription factors and promoting 
its transcription. To answer that, we performed ChIP experiment on the 
miR-101 promoter. In the Fig. 25a are showed the chromosome location of 
miR-101 locus and the recognized sequences of the primers used for the 
chromatin immunoprecipitation. We observed no significant difference 
between ‘healthy’ and GDM-HUVECs in the EZH2 occupancy on regulatory 
sequences of miR-101 locus, but a trend toward lower levels in the GDM-
HUVECs compared to the controls (Fig. 25b). 
 
3.8 MiR-101 increases after long exposure to high D-glucose in treated 
HUVECs (from healthy mothers) 
It has been already widely shown that hyperglyceamia inhibits EC 
migration in vitro [62, 63] and impairs angiogenesis in vivo and in vitro [64, 
65]. However, the effects are related to the time and the concentration of D-
glucose, beside of others experimental conditions. In fact, short treatment 
and/or medium concentrations of D-Glucose, reportedly enhanced ECs 
function through different intracellular signalling pathway [66]. 
To study the functional and molecular effect of hyperglycaemia in vitro, we 
treated the HUVECs extracted from ‘healthy’ mothers, for 12-24-48 hours 
with high glucose, as specified in the methods. The Fig. 26 summarise the 
impact of hyperglyceamia in vitro on capillary-like tube formation on 
Matrigel. In the first 12 hours, 25mM and 12.5mM D-glucose (respectively 
indicated with HHD-Glu and HD-Glu) did not influence the HUVECs 
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angiogenic capacity; an increased angiogenesis response was observed  after 
24h in 12.5mM of D-glucose (HD-glu) (P<0.05 vs normal condition–N-). A 
longer exposure to hyperglycaemia in vitro impairs the angiogenic capacity: 
after 48 hours of treatment with 25mM of D-glucose (HHD-glu) the total 
length of tube decreased strongly compared to the controls. On the other 
side, the same concentration of 25mM of L-glucose (HHL-glu), and the 
12.5mM of D- and L-glucose (HD-glu and HL-glu) have determined an 
improvement in the networking of tubes compare with the normal condition 
(N). The response to biologically inactive L-glucose observed is a result of 
increased osmolarity. 
Then we checked in miR-101 levels and, as it’s showed in the Fig. 27, after 
24h of treatment with 25mM of D-glucose, miR-101 decreased and EZH2 
(mRNA and levels) tends to a decreased (not statistically significant). But 
after 48 hours of treatment, with 25mM of D-glucose, miR-101 increased in 
25mM D-glucose treated HUVECs (P <0.05 vs N), as in the analysed GDM 
cells. The model in vitro mimic the condition of hyperglyceamia in which are 
exposed the GDM extracted HUVECs in utero during the pregnancy, at 
least in the miR-101 up-regulation, in fact not significant differences has 
been found in EZH2 mRNA and protein levels (Fig. 28a, b). 
 
3.9 MiR-101 increases after long exposure of D-glucose due to the 
diminished EZH2 occupancy at the promoter level 
We performed the Chromatin Immunoprecipitation (ChIP) experiment on 
the miR-101 promoter region using antibody against EZH2 and H3K27m3, 
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as specified in the methods. Two set of primers have been used to amplify 
the putative EZH2 binding regions on miR-101 locus (Fig. 25a). The 
chromatin samples were obtained from one 'healthy' HUVECs lineage 
exposed for 48 hours to 25mM or 5mM of D-Glucose. That preliminary data, 
presented in the Fig. 29, shows that the occupancy of EZH2 on the miR-101 
locus regulatory region is lesser in those HUVECs treated with high glucose 
compare with the normal control. That result is in accordance with the 
previous observance showing increased of miR-101 after long exposure of 
high D-glucose compared to the controls and, if confirmed with more 
experiments, could give an important explanation on how hyperglycaemia 
leads molecular and expressional alterations, influencing epigenetic 
regulator as EZH2 and its binding on the miR-101 locus. 
 
3.10  The “glyceamic memory” studied in vitro 
Having found the up-regulation of miR-101 in vitro, after 48 hours of 
treatment with high concentration of D-glucose, we wanted explore the 
persistence of that upregulation, after returned to normal glucose. We 
performed the “glyceamic memory” experiment culturing ‘healthy’ HUVECs 
with 25mM of D-Glucose for 48h, then in normal D-glucose for 5, 10 and 24 
hours. Then we analysed miR-101 levels to explore if recovered cells return 
to normal miR-101 levels. The graph in Fig. 30 shows that miR-101 tends to 
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3.10 MiR-101 increases after long exposure to high D-Glucose due to the 
diminished EZH2 occupancy at the promoter level 
‘Healthy’ HUVECs exposed for 48 hours to high or normal concentration of 
D-Glucose have been fixed, as specified in the methods, and prepared for the 
chromatin immunoprecipitation. As shown in the Fig. 31, the occupancy of 
EZH2 on the miR-101 locus regulatory region is lesser in those cells treated 
with high glucose compare with the normal control (N=1). That result is in 
line with the previous results: the miR-101 upregulation under high glucose 
condition in vitro and under chronic diabetic condition in utero. Moreover, it 
gives an important explanation how hyperglyceamia leads 
molecular/expressional alterations, influencing epigenetic regulator, as 
EZH2 and its binding on miR-101 locus, in turn promoting miR-101 
transcription and the consequent EZH2 down-regulation. 
 
3.11 Histological analysis of placental tissue from ‘healthy’ and GDM 
mothers 
As specified in the methods, both GDM and ‘healthy’ placenta tissue has 
been collected and used for histological analysis (N=2).   
The Hematoxylin-Eosin staining showed that the mesenchymal tissue of 
intermediate villi was denser and stained more intensely in GDM derived 
placenta than in normoglycemic women (Fig. 32). The mesenchyme 
normally has a loose arrangement, with numerous capillaries and is closely 
connected with the syncytiotrophoblast, while the placenta of women with 
GDM showed very dense mesenchyme, with fewer villous capillaries. 
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The Picrosirius Red staining revealed a greater condensation of collagen 
material organized around the vessels and villous stroma in placentas of 
women with gestational diabetes (Fig. 32).  Our considerations are 
preliminary data needed confirmations because derived from just four 





















Ilaria Floris, “Characterisation of molecular and phenotypic effects induced by Gestational Diabetes 
Mellitus (GDM) on endothelial cells and placenta tissue”, PhD thesis in Biochemistry, Physiology and 
Molecular Biology of PhD School in Biomolecular and Biotechnological Sciences, University of Sassari 
    4  DISCUSSION AND CONCLUSION  
Epidemiologic studies suggest that intensive glyceamic control cannot 
reverse pre-established hyperglyceamia molecular and phenotypic 
alterations on endothelial cells. The involvement of epigenetic modifications 
and interconnected non-coding RNA-based mechanisms on ‘glyceamic 
memory’ reveal how heritable alterations, induced by transient 
hyperglyceamia, can persist and progress, even in normal glucose condition. 
That concept needs more detailed studies and, in this report we wanted 
contribute giving new experimental evidence in the field of gestational 
diabetes mellitus and its vascular complication.  
In our study we firstly characterised the long-term effect of maternal 
gestational diabetes mellitus on the umbilical cord vein endothelial cells by 
functional assays in vitro and, not surprisingly, we observed impairment in 
endothelial cell phenotype in those cells derived from gestational diabetic 
mothers compared to the ‘healthy’ controls. Our findings were consistent 
with the hypothesized mechanisms where chronic hyperglyceamia can lead 
to long lasting endothelial dysfunction. In particular, we noticed that GDM-
HUVECs showed reduced angiogenic capacity (analysed with Matrigel 
assay); lower proliferative index after stimulation with foetal bovine serum 
(FBS); impaired migration capacity (measured by scratch assays); and 
increased apoptosis, in comparison with HUVECs derived from ‘healthy’ 
controls. All functional assays were performed after five-six passages in 
culture in normal D-glucose (5mM); that reveal that the cells were still 
affected by the previous chronic hyperglyceamia in utero.  
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We aimed to investigate in microRNA deregulations and epigenetic 
modifications induced by the diabetic uterine environment on foetal 
umbilical vein endothelial cells. We started with miRs-screening of the miRs 
belonging to the miR-16 family [56], which we already found upregulated in 
endothelial cells and other proangiogenic cells when diabetes mellitus was 
associated with critical limb ischemia [57, 58]. In comparison with Ctr-
HUVECs, the GDM-HUVECs showed a tendency toward higher levels of the 
miR-16 family, miR-503 especially, but without statistical significance. 
Then we examine miR-101 levels and the other components of the FGF2-
VEGF/KDM2B/EZH2-miR-101-EZH2 axis, never investigated before the 
field of diabetes and its vascular complications. The two growth factors 
FGF2 and VEGF are able to activate the axis and inhibit miR-101 
promoting angiogenesis [45]. In our report we showed lower FGF2 and a 
trend toward lower VEGF levels in conditioned medium from GDM derived-
HUVECs compared to the ‘healthy’ controls. 
Other reports have studied miR-101 in endothelial cells attributing an anti-
angiogenic role, in part via inhibition of Enhancer of Zester Homolog 2 
(EZH2) [40]. We discovered higher miR-101 levels in the GDM-HUVECs 
compare with the controls (P<0.05) and a high positive Pearson’s correlation 
between the miR-101 levels and the apoptosis (Pearson r = 0.9, P<0.001). 
Furthermore, increased miR-101 levels are accompanying with diminished 
levels of its target genes EZH2, both mRNA and protein, and reduced 
H3K27m3 global levels. In fact, H3K27m3 represents a covalent and thus 
lasting histone modification that can be removed by histone demethylases 
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[34]. EZH2 is essential for the H3K27m3 propagation and maintenance and 
its decrease or loss would lead to detectable reduction of H3K27m3 mark, as 
we found, with alteration in gene expression and endothelial function. A 
recent study, aimed to understand the role of EZH2 in the control of gene 
expression in endothelial cells, have identified 946 genes upregulated by >2-
fold due to EZH2 knockdown, in accordance with its repressive function. 
Importantly, many of these genes are implicated in endothelial cell 
dysfunctions and cardiovascular disease [42].   
We demonstrated that, the induced up-regulation in vitro of EZH2 by anti-
miR-101 in the GDM cells decreased their levels of apoptosis and improved 
the angiogenic phenotype affected by hyperglyceamia in utero, restoring the 
endothelial tube formation on Matrigel as the control lineages. On the other 
side, the inhibition of EZH2 through pre-miR-101 transfection reduced cell 
vitality (Trypan blue exclusion assay), reduced the migration (scratch assay) 
and the angiogenic capacity (matrigel assay), capacities already 
compromised of the GDM-HUVECs.  
In the light of our results, we wanted also deeper explore the effect of EZH2 
knock down in GDM-HUVECs and especially in anti-miR-101 transfected 
GDM-HUVECs. We observed increased levels of miR-101 due to EZH2 KD 
(P<0.05), in accordance with published study [45] and augmented apoptosis. 
Surprisingly, the GDM-HUVECs in vitro angiogenic capacity, seems not be 
influenced by the EZH2 KD, differently from what we observed in the pre-
miR-101 transfected cells. One possible explanation might be that the levels 
of miR-101 reached with pre-miR-101 are much higher than the miR-101 
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levels in EZH2 KD transfected GDM cells. That could make the difference 
because the alterations in miRs expressional levels may affect 
proportionally the cell phenotype, depending on the range of target gene 
interested. In fact, miR-101 can influence many other proteins, and 
directly/indirectly influence a variety of target genes, not just EZH2 [67, 68, 
69]. 
We confirmed with an in vitro model of hyperglycaemia that high glucose 
significantly impaired the function of HUVECs, as shown in many reports, 
with the novelty of concomitantly upregulation of miR-101 after long 
exposure to D-Glucose (48h with 25mM of D-Glucose, compared to the 
normoglycemic and osmotic controls). Importantly, the ChIP on the miR-101 
locus permitted to detect the occupancy of EZH2 on regulatory region and to 
discover that is lesser in those HUVECs treated with high glucose compare 
with the normal control (P<0.05). That result explain how hyperglycaemia 
leads molecular and expressional alterations, influencing epigenetic 
regulator as EZH2 and its binding on the miR-101 locus, in turn, promoting 
miR-101 transcription and its consequent up-regulation. Higher miR-101 
may stabilise the EZH2 down-regulation, influencing gene expression and 
the endothelial cell phenotype. 
Our study is in line with the ‘glyceamic memory’ theory, where chronic 
hyperglycaemic conditions lead persistent outcomes, through epigenetic 
changes and alterations in miRs levels. That finding can also contribute to 
the knowledge about the molecular pathways activated by hyperglycaemia 
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in utero on the foetal endothelial cells, opening ways to new targets and 
novel future therapeutic interventions. 
The histological analysis of the placenta tissue demonstrated that the 
mesenchyme of the placenta from GDM women is denser than the normal 
placenta due to the accumulation in collagen material. Our analysis 
confirmed previous studies in which hyperglyceamia has been associated 
with higher production of collagen by the vascular endothelium [55] and also 
intensified deposition of the extracellular vascular amyloid, which consists 
on a heterogeneous mix of fibrillar proteins [53, 54]. The production of these 
proteins may explain the appearance of more condensed mesenchyme 
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    5  FIGURES   
 
 
Fig. 1  
The “Pedersen’s hyperglycaemia-hyperinsulinemia hypothesis”   
In diabetic condition, the high amount of maternal D-glucose can cross the 
placental barrier becoming available to the foetus, establishing chronic 
foetal hyperglyceamia. The maternal insulin does not cross the placenta and 
the developing foetal pancreas responds to a D-glucose load by increasing 
synthesis and release of insulin, which acts as a foetal growth hormone. 
This is the basic concept of the “Pedersen’s hyperglycaemia-hyperinsulinism 
hypothesis”, where foetal overgrowth due to hyperinsulinemia is the 
response to increased transplacental D-glucose transfer.  
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Fig.2  
Role of Enhancer of Zester Homolog2 (EZH2) 
The protein Enhancer of Zester Homolog2 (EZH2) is a well-characterized 
regulator of the epigenome. It’s the only protein of the Policomb Repressor 
Complex2 (PRC2) with a histone methyltransferase activity that initiates 
and maintains the methylation of Lys27 (H3K27) on histone H3.  
According to the ‘histone code’ hypothesis, histone marks are deposited by 
‘writer’ proteins and recognized by ‘reader’ proteins. EZH2, together with 
PRC2 and with chromatin regulators trigger the transition between open 
(permissive) to close (non-permissive) chromatin, regulating gene 
transcription. In fact, the epigenetic mark H3K27m3 mediates the long term 
epigenetic gene silencing.  
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Principal miRNAs involved in ECs function. 
Table showing some of the principal microRNAs involved in proliferation, 
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Characteristics of the healthy mothers and gestational diabetes mellitus 
(GDM) mothers  
The table shows the characteristics of the ‘healthy’ (N=24) and gestational 
diabetic (N=22) mothers, donors of the umbilical cords from which have 
been extracted the HUVECs for the study. 
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Fig. 3 
FGF2 or VEGF-KDM2B/EZH2-miR-101-EZH2 axis 
FGF2 and VEGF regulate cell proliferation, migration and angiogenesis, in 
part through the phosphorylation of CREB, the consequent NDY/KDM2B 
upregulation and the recruitment of basally expressed EZH2. The complex 
NDY/KDM2B/EZH2 acts in several regulatory sequences leading gene 
repression. In particular, it binds and represses the miR-101 locus 
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Fig.4 
Histological analysis of placenta  
The chorionic villi gradually branched into intermediate and terminal villi, 
which are surrounded by a syncytiotrophoblast layer and syncytial knots, 
formed by group of nuclei. The maternal blood circulates in the intervillous 
space, while the foetal blood is separated from maternal blood by the 
placental membrane. The centre of the villi contained loose mesenchymal 
tissue with fibroblasts, macrophages and blood vessels. The structure and 
size of vessels into the villi is proportional to the thickness, small villi 
contained only capillaries (foetal capillaries). 
 
49 
Ilaria Floris, “Characterisation of molecular and phenotypic effects induced by Gestational Diabetes 
Mellitus (GDM) on endothelial cells and placenta tissue”, PhD thesis in Biochemistry, Physiology and 
Molecular Biology of PhD School in Biomolecular and Biotechnological Sciences, University of Sassari 
 
Fig. 5 
Flow cytometry for endothelial marker (CD31-positive/PI negative) in 
‘healthy’ controls and GDM lineages 
The purity of the cells has been investigated by FACS using the endothelial 
marker CD-31. As the figure shows, both GDM-HUVECs and Ctr-HUVECs 
are CD-31 positive (≥95%). 
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Fig. 6 
Analysis of capillary-like tube formation on Matrigel 
The HUVECs extracted from gestational diabetes mellitus (DGM) mothers 
have lower angiogenic capacity, measured analysing the network formed on 
Matrigel, compared to the control group of HUVECs. Data are presented as 
mean SEM. The data are obtained from a triplicate of n=12 (Control 
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Fig. 7 
BrdU incorporation assay in response to FBS 
The HUVECs extracted from gestational diabetes mellitus (DGM) mothers 
have lower proliferative capacity in response to FBS. Briefly, both lineages 
were cultured for 1 hour in strong serum starved condition (EGM2 without 
FBS), then for 24 hours in EGM2 (0.5% FBS) or in normal condition. 
Proliferative index has been calculated by the ratio between the BrDu 
incorporation values in starved condition and in normal condition, for each 
lineage. The data are obtained from n=7 Controls and n=6 GDM-HUVECs. 
Data are presented as mean SEM.  ** p value < 0.005, as compared with 
control group. 
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Fig. 8 
Analysis of hound healing in vitro by scratch assay 
The HUVECs extracted from gestational diabetes mellitus (DGM) mothers 
have lower capacity of closing scratch compared the control group of 
HUVECs extracted from healthy mothers. Data are presented in mm2/hour, 
as mean SEM. The data are obtained from n=10 Controls and n=8 GDM 
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 Fig. 9 
The results of the levels of apoptosis of measured with the ELISA kit 
The graph shows an increase of apoptosis in the gestational diabetic 
mellitus (DGM) mothers extracted lineages compare the controls. Data are 
presented as mean SEM. The data are obtained from n=11 Control HUVECs 
and from n=8 GDM-HUVECs.   
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MicroRNAs screening for miR-16 family 
HUVECs from ‘healthy’ and from GDM mothers (N=8) has been screened for 
the microRNAs belonging to the extended miR-16 family (miR-15a, miR-15b, 
miR-16, miR-103, miR-107, miR-195, miR-424 and miR-497, miR-503) 
already found upregulated in endothelial cells and other proangiogenic cells 
in the field of diabetes mellitus associated with critical limb ischemia. We 
found a trend towards increased levels in GDH HUVECs compare with the 
‘healthy’ lineages, but without statistical significance. 
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The miR-101 levels and EZH2 (mRNA and protein) levels evaluated in 
gestational diabetic and healthy HUVECs lineages 
The levels of miR-101 (a) and EZH2 mRNA (c) analysed in GDM and control 
HUVECs, with the respective distribution with respect median (b&d). Their 
values are negative correlated (Pearson r =-0.4, p value < 0.05), as is showed 
in the graph of the Linear Regression (e). miR-101 levels are higher in the 
GDM-HUVECs compared to the controls, while EZH2 mRNA and protein 
levels (f), measured by Western blot normalising with LaminA/C, are lower 
respect to the controls. Coherently with EZH2 levels, even the epigenetic 
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mark H3K27m3 normalised to Histone H3, is lower in the GDM lineages 
compare with the controls. All RT-PCR data are presented as mean SEM. 
* p value <0.05,  as compared with control group. 
    
 
Fig. 12 
Positive Pearson’s Correlation between miR-101 levels and apoptosis 
HUVECs from ‘healthy’ and GDM mothers has been analysed in their miR-
101 levels and apoptosis. The graph shows that their levels are highly 
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FGF2 and VEGF secreted levels evaluated in gestational diabetic and 
healthy HUVECs 
GDM-extracted HUVECs and healthy lineages were cultured in serum 
starved condition for 24hours (as specified in the methods). We collected the 
conditioned medium, and then we measured the levels of FGF2 (a) and 
VEGF (b) by ELISA. GDM HUVECs secreted lower FGF2 compared to the 
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The components of the VEGF-A/KDM2B/miR-101/EZH2 axis measured on 
the HUVECs extracted from healthy and gestational diabetic mothers. 
The mRNA levels of KDM2B (a) and VEGF (b) measured in gestational 
diabetic extracted HUVECs tend to lower levels compare with the control 
lineages, but there is no a significant difference. The mRNA levels of VEGF 
are correlated positively with the EZH2 mRNA levels according to the axis 
(c); again EZH2 and KDM2B are positively correlated (d), conversely 
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Relative expression of miR-101 and EZH2 mRNA levels in pre-miR-101, 
anti-miR-101 or scramble transfected HUVECs 
The two graphs represent the relative expression of miR-101 (a) and EZH2 
mRNA (b) in Control HUVECs and GDM-HUVECs, both transfected with 
scramble, and GDM lineages also with pre-miR-101 and anti-miR-101. Data 
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Fig. 16 
EZH2 and H3K27m3 protein levels analysed by Western blot in pre-miR-
101, anti-miR-101 or scramble transfected GDM HUVECs 
The two graphs represent the protein levels of EZH2 and H3K27m3, 
respectively normalised to LaminA/C and Histone H3, in GDM-HUVECs 
transfected with scramble, pre-miR-101 and anti-miR-101. Data are 
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Role of miR-101 in GDM lineages: in cell viability, in apoptosis and in 
capillary-like tube formation on Matrigel 
GDM lineages were transfected with pre-miR-101, anti–miR-101, or 
scramble; also the control lineages transfected with scramble. (a) Then have 
been analysed the cell viability with Trypan Blue as % of alive cells/total 
cells; (b) the levels of apoptosis, calculated in fold change, normalizing to the 
average of the scramble (GDM lineages) values, as a control.   
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All data are expressed as mean SEM.   * p value < 0.05  as compare with 
SCRAMBLE (GDM lineages),  *** p value < 0.0005 as compare with 




Role of miR-101 in hound healing in vitro assay (scratch assay) in GDM 
lineages 
GDM lineages (N=3) were transfected with pre-miR-101, anti–miR-101, or 
scramble; also the control lineages transfected with scramble. The induced 
miR-101 overexpression decreased the migrative capacity of the GDM-
HUVECs compare with the scramble control. The migrated area of the 
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wound edge was quantified as mm2/hour. Scale bar = 0.5mm. Data are 
presented as mean SEM (n = 3).  




EZH2-siRNA-mediated knock down in healthy and GDM lineages 
HUVECs have been transfected with EZH2-siRNA and siRNA-Ctr, as 
specified in the methods. Then, nuclear fractions has been extracted and 
analysed by Western blot. EZH2 and H3K27m3 protein levels decreased in 
EZH2-siRNA transfected cells compare with the controls. Data are 
presented as mean SEM (n = 3).  
 * p value <0.05, as compared with siRNA-Ctr group. 
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Fig. 20 
EZH2 knock down leads the upregulation of miR-101 in EZH2-siRNA 
transfected GDM-HUVECs compared to the siRNA-Ctr 
Control and GDM lineages (N=3) were transfected with EZH2-siRNA, or 
siRNA-Ctr . The graph shows the increased miR-101 levels after EZH2 KD 
in GDM-HUVECs (P<0.05 vs siRNA-Ctr). All data are expressed as mean 
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EZH2 knock down in GDM-HUVECs increased apoptosis compared to the 
siRNA-Ctr, while doesn’t affect significantly the network on Matrigel  
GDM lineages (N=3) were transfected with EZH2-siRNA, or siRNA-Ctr then 
analysed in the levels of apoptosis and in angiogenic capacity in vitro.  
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(a) The apoptosis of the GDM extracted HUVECs increased in EZH2-siRNA 
compare with the siRNA-Ctr, (b) while the angiogenic capacity is not 
affected by the EZH2 KD. All data are expressed as mean SEM.  




Relative miR-101 quantification between GDM-HUVECs transfected with 
pre-miR-101, anti-miR-101, EZH2-siRNA, siRNA-Ctr, scramble, and 
‘healthy’ HUVECs with the only scramble 
GDM-HUVECs (N=3) were transfected with pre-miR-101, anti-miR-101, 
EZH2-siRNA, siRNA-Ctr, scramble while ‘healthy’ HUVECs transfected 
with the only scramble control, as a reference. Then, miR-101 levels have 
been measured. All data are expressed as mean SEM.  * p value <0.05  as 
compare with scramble (GDM-HUVECs);  # p value <0.05  as compare with 
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EZH2 mRNA and miR-101 levels in co-transfected GDM-HUVECs 
GDM-HUVECs (N=4) has been cotransfected with siRNA-Ctr/scramble, 
siRNA-Ctr/anti-miR-101, or EZH2-siRNA/anti-miR-101. The cotransfection 
efficacy has been tested by (a) EZH2 mRNA and (b) miR-101 levels.  
 * p value <0.05, as compared with siRNA-Ctr/scramble; ** p value <0.005, 
as compared with siRNA-Ctr/scramble; # p value <0.05, as compared with 
siRNA-Ctr/anti-miR-101. 
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Fig. 24 
Effect of the anti-miR-101 with the simultaneously EZH2 inhibition in GDM 
lineages on apoptosis and on capillary-like tube formation 
GDM lineages (N=4) were co-transfected with EZH2-siRNA/anti-miR-101, 
anti–miR-101/siRNA-Ctr, or scramble/siRNA-Ctr. We analysed the levels of 
apoptosis (a), calculated in fold change, normalizing to the average of the 
scramble/siRNA-Ctr, as a control (b) and the angiogenic capacity in vitro by 
matrigel assay. All data are expressed as mean SEM.  * p value < 0.05 as 
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Fig. 25 
Scheme showing the location of the miR-101 locus, the set of primers used 
for ChIP and the EZH2occupancy on putative regulatory sequences in 
‘healthy’ and GDM-HUVECs 
MiR-101-1 gene is located in the chromosome 1, (chr1: 65,524,117-
65,524,191, [-]) and is negative-strand transcribed. (a) In the figure are 
indicated the transcription starting site (TSS) putative region and the 
regions amplified by the two set of primers used for the ChIP experiment. 
(b) The graphs show the EZH2 occupancy on putative regulatory regions of 
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Long exposure to D-Glucose impairs the angiogenic capacity of HUVECs in 
vitro 
Graph and representative images of the effect of glucose on angiogenic 
capacity in human umbilical vein endothelial cells (HUVECs) exposed to 
control level (5.5 mM = N) and high levels of D-glucose (25 mM and 12.5 
mM, respectively HHD-glu and HD-glu) and L-glucose, used as osmotic 
control (HHL-glu and HL-glu), at different time periods (12, 24, 48h). Data 
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are presented as mean SEM (n = 3). * p value < 0.05, as compared with 





MiR-101 levels in high glucose treated HUVECs (from healthy donors) 
‘Healthy’ HUVECs were cultured in high glucose to mimic the diabetic 
hyperglycaemia (as specified in the methods) for 24 and 48hours. MiR-101 
decreased after 24hours with 25mM of D-glucose compared to the normal 
and osmotic controls (P<0.05). Then, after 48hours miR-101 increased, as in 
GDM-extracted HUVECs (P<0.05 compare with normal control –N and 
osmotic control). 
72 
Ilaria Floris, “Characterisation of molecular and phenotypic effects induced by Gestational Diabetes 
Mellitus (GDM) on endothelial cells and placenta tissue”, PhD thesis in Biochemistry, Physiology and 




EZH2 (mRNA and protein levels) evaluated in ‘healthy’ HUVECs treated 
with high glucose 
In the figure are showed the EZH2 mRNA levels (a) and EZH2 protein 
levels (b) normalized to tubulin analysed by western blot. Briefly HUVECs 
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were treated with 12.5mM and 25mM of D-/L- glucose for 24 and 48h, as 





EZH2 occupancy at the miR-101 regulatory region in high glucose treated 
HUVECs 
Only one ‘Healthy’ HUVECs lineage were exposed for 48 hours to high or 
normal concentration of D-Glucose, then fixed, as specified in the methods, 
and prepared for the chromatin immunoprecipitation. The graph in the 
figure describes the occupancy of EZH2 on the miR-101 locus regulatory 
region. It shows that the EZH2 binding is lesser in those cells treated with 
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Fig. 30 
The ‘glyceamic memory’ in vitro 
We performed the “glyceamic memory” experiment culturing ‘healthy’ 
HUVECs with 25mM of D-Glucose for 48h, then in normal D-glucose for 5, 
10 and 24 hours. The graph shows that miR-101 levels, as previously 
described, increased in those cells exposed for 48 hours to 25mM of D-
glucose then, if return to normal glucose, miR-101 tends to higher levels 
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Fig.  31 
Hematoxylin-Eosin staining of placenta from ‘healthy’ and GDM mothers 
The Hematoxylin-Eosin staining showed that the mesenchymal tissue of 
intermediate villi appears denser and more intensely stained in GDM 
derived placenta than in normoglycemic women. The mesenchyme of the 
normal placenta has a loose arrangement, with numerous capillaries, while 
the placenta of women with GDM showed very dense mesenchyme, with 
fewer villous capillaries. (Preliminary Data) 
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Picrosirius Red staining of placenta tissue from ‘healthy’ and GDM donors 
The figure Picrosirius Red staining reveals a greater condensation of 
collagen material around the vessels and villous stroma in placentas of 
women with gestational diabetes in comparison with the placentas of 
‘healthy’ donors (N=2). The quantification has been performed analysing the 





Ilaria Floris, “Characterisation of molecular and phenotypic effects induced by Gestational Diabetes 
Mellitus (GDM) on endothelial cells and placenta tissue”, PhD thesis in Biochemistry, Physiology and 




We propose that the chronic hyperglyceamia in utero leads to conserved 
“glyceamic memory” in culture. In our study, GDM-HUVECs have higher 
miR-101 levels compare with the controls, and reduced levels of the target-
gene EZH2, both mRNA and protein levels. Moreover, lower EZH2 de-
repress the miR-101 transcription stabilising the upregulation of miR-101. 
These molecular changes, accompanied by phenotypic alteration in vitro, 
were present after 5-6 passage in culture in normal D-Glucose condition. 
Therefore, are persistent alterations due to the precedent hyperglycaemic 
environment, conserved “memory” of the cells, even if cultured in normal D-
glucose. 
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